“On another issue, if he were to leave what would be the new primary fudster talking point?”
Well, I don’t consider myself a FUDster since all I’m doing is expressing my opinions of our CEO’s performance and that of the board of directors in coddling him. I’ve NEVER said or even implied that anyone should sell and I don’t care what anybody does with their money except to behave in a financially responsible manner. However, to answer your accusatory question, I personally would have nothing negative to say. If a competent CEO were hired and that person had a track record of success in drug development, business development, regulatory affairs, and commercialization leading to enhanced shareholder value, I would 1) Add to my position, and 2) Sit back and give it additional time.
News 
Market Data 
Discover 
